TherapeuticsMD, Inc. Common Stock TXMD
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T02:48:05.206Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:47:52.990638792Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-12T02:48:04.890092+00:00
TherapeuticsMD, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 2.08 | 313.7% | 28.9% | |||
| 55Δ | 1.91 | 320.0% | 23.2% | 2.02 | 216.0% | 9.3% |
| 60Δ | 1.77 | 341.1% | 20.6% | 2.24 | 241.0% | 8.3% |
| 65Δ | 1.64 | 362.3% | 18.0% | 2.47 | 266.0% | 7.4% |
| 70Δ | 1.50 | 383.4% | 15.4% | 2.69 | 290.9% | 6.5% |
| 75Δ | 1.36 | 404.5% | 12.8% | 2.91 | 315.9% | 5.6% |
| 80Δ | 1.23 | 425.7% | 10.2% | 3.20 | 321.2% | 4.4% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 2.08
- IV
- 313.7%
- B/E move
- 28.9%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 1.91
- IV
- 320.0%
- B/E move
- 23.2%
- Pseudo strike
- 2.02
- IV
- 216.0%
- B/E move
- 9.3%
60Δ
- Pseudo strike
- 1.77
- IV
- 341.1%
- B/E move
- 20.6%
- Pseudo strike
- 2.24
- IV
- 241.0%
- B/E move
- 8.3%
65Δ
- Pseudo strike
- 1.64
- IV
- 362.3%
- B/E move
- 18.0%
- Pseudo strike
- 2.47
- IV
- 266.0%
- B/E move
- 7.4%
70Δ
- Pseudo strike
- 1.50
- IV
- 383.4%
- B/E move
- 15.4%
- Pseudo strike
- 2.69
- IV
- 290.9%
- B/E move
- 6.5%
75Δ
- Pseudo strike
- 1.36
- IV
- 404.5%
- B/E move
- 12.8%
- Pseudo strike
- 2.91
- IV
- 315.9%
- B/E move
- 5.6%
80Δ
- Pseudo strike
- 1.23
- IV
- 425.7%
- B/E move
- 10.2%
- Pseudo strike
- 3.20
- IV
- 321.2%
- B/E move
- 4.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 169.60% | |
| 150.18% | |
| 226.78% |
Drug Manufacturers - Specialty & Generic
UTHR
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with…
More →VTRS
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
More →XERS
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in…
More →ZTS
Description unavailable
More →ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products globally. The company is headquartered in Edmonton, Canada.
More →AKBA
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. The company is…
More →